Loading...
Loading...
Among the 5 tracked institutional investors we monitor, SABS (SAB BIOTHERAPEUTICS INC) is held with a combined value of $20.23M across 5,324,990 shares. The largest holder is MILLENNIUM MANAGEMENT LLC with a position worth $11.62M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 4 funds increased their holdings.
Total Institutional Value
$20.23M
Total Shares Held
5,324,990
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | $11.62M | 0.00% | +835.8% |
| 2 | VANGUARD GROUP INC | $6.91M | 0.00% | New |
| 3 | BlackRock, Inc. | $1.15M | 0.00% | +1647.9% |
| 4 | STATE STREET CORP | $284.31K | 0.00% | +465.7% |
| 5 | CITADEL ADVISORS LLC | $266.57K | 0.00% | +294.3% |
As of the latest SEC 13F filings, MILLENNIUM MANAGEMENT LLC is the largest institutional holder of SABS with a position worth $11.62M, representing 0.00% of their portfolio. In total, 5 institutional investors hold SABS with a combined value of $20.23M.
In the most recent quarter, 1 fund opened a new position in SABS. Additionally, 4 increased their holdings.
Institutional investors hold $20.23M worth of SABS stock across 5 positions. The largest institutional holder is MILLENNIUM MANAGEMENT LLC with $11.62M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For SABS, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their SABS positions.